Objective To identify a potential disease-causing mutation in the FBN1 gene in a Chinese family with ectopia lentis （EL）. Methods Case series study. Complete physical， ophthalmic and cardiovascular examinations of all family members were conducted. Peripheral blood samples were collected from the proband and his family members with informed consents. Genomic DNAs were isolated from peripheral blood leukocytes. All 65 exons and exon-intron boundaries of the FBN1 gene were amplified by polymerase chain reaction （PCR）. After purification， the PCR products were bidirectionally sequenced. Results All 3 ectopia lentis individuals were found to carry a novel missense mutation of c.1999T>C （p.Cys 515Arg） in FBN1 that is predicted to be harmful by the SIFT and Polyphen-2， while normal members of the family did not have this mutation. Furthermore， subject Ⅱ-2 and Ⅲ-1 did not show detectable abnormalities in the cardiovascular system compared to Ⅰ-2， who had ascending aorta dilation. Conclusion The EL family patients with the c.1999T>C （p.Cys 515Arg） mutation in the FBN1 gene showed different cardiovascular presentation. However， whether the younger mutation carriers of the family will evolve towards Marfan′s syndrome with aging needs long-term observation.
崔云,马良,尚艳峰,李聪慧,李丹,蔡涛. FBN1基因新突变导致常染色体显性遗传眼病晶状体脱位一家系三例分析[J]. 中华眼视光学与视觉科学杂志, 2015, 17(7): 416-419.
Cui Yun,Ma Liang,Shang Yanfeng,Li Conghui,Li Dan,Cai Tao. Identification of a novel mutation of the FBN1 gene in a Chinese family with inherited ectopia lentis. Chinese Journal of Optometry Ophthalmology and Visual science, 2015, 17(7): 416-419. DOI: 10.3760/cma.j.issn.1674-845X.2015.07.008
Turner CL， Emery H， Collins AL， et al. Detection of 53 FBN1 mutations （41 novel and 12 recurrent） and genotype-phenotype correlations in 113 unrelated probands referred with Marfan syndrome， or a related fibrillinopathy[J]. Am J Med Genet A，2009，149A（2）：161-170.
[2]
Schrijver I， Liu W， Brenn T， et al. Cysteine substitutions in epidermal growth factor—like domains of fibrillin-l： distinct effects on biochemical and clinical phenotypes[J]. Am J Hum Genet，1999，65（4）：1007-1020.
[3]
Attansaio M， Lapini I， Evangelisti L， et al. FBN1 mutation screening of patients with Marfan syndrome and related disorders： Detection of 46 novel FBN1 mutations[J]. Clin Genet，2008，74（1）：39-46.
[4]
Robinson PN， Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillopathies[J]. J Med Genet，2000， 37（1）：9-25.
[5]
Loeys BL， Dietz HC， Braverman AC， et al. The revised Ghent nosology for the Marfan syndrome[J]. J Med Genet，2010，47（7）：476-485.
[6]
Zadeh N， Bernstein JA， Niemi AK， et al. Ectopia lentis as the presenting and primary feature in Marfan syndrome[J]. Am J Med Genet A，2011，155A(11)：2661-2668.
[7]
Adès LC， Holman KJ， Brett MS， et al. Ectopia lentis phenotypes and the FBN1 gene[J]. Am J Med Genet A，2004，126A（3）：284-289.
[8]
Détaint D， Faivre L， Collod-Beroud G， et al. Cardiovascular manifestations in men and women carrying a FBN1 mutation[J]. Eur Heart J，2010，31（18）：2223-2229.
[9]
Whiteman P， Handford PA. Defective secretion of recombinant fragments of fibrillin-1： implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders[J]. Hum Mol Genet，2003，12（7）：727-737.
[10]
Milewicz DM1， Urbán Z， Boyd C. Genetic disorders of the elastic fiber system[J]. Matrix Biol，2000，19（6）：47l-480.
[11]
Reinhardt DP， Ono RN， Notbohm H， et al. Mutation in calcium-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis. A potential disease-causing mechanism in Marfan syndrome[J]. J Biol Chem，2000，275（16）：12339-12345.
浙公网安备 33030202001892号